Literature DB >> 30833271

The Immune Subtypes and Landscape of Squamous Cell Carcinoma.

Bailiang Li1, Yi Cui1, Dhanya K Nambiar1, John B Sunwoo2,3, Ruijiang Li4,3.   

Abstract

PURPOSE: To identify immune subtypes and investigate the immune landscape of squamous cell carcinomas (SCC), which share common etiology and histologic features. EXPERIMENTAL
DESIGN: Based on the immune gene expression profiles of 1,368 patients with SCC in the Cancer Genome Atlas (TCGA), we used consensus clustering to identify robust clusters of patients and assessed their reproducibility in an independent pan-SCC cohort of 938 patients. We further applied graph structure learning-based dimensionality reduction to the immune profiles to visualize the distribution of individual patients.
RESULTS: We identified and independently validated six reproducible immune subtypes associated with distinct molecular characteristics and clinical outcomes. An immune-cold subtype had the least amount of lymphocyte infiltration and a high level of aneuploidy, and these patients had the worst prognosis. By contrast, an immune-hot subtype demonstrated the highest infiltration of CD8+ T cells, activated NK cells, and elevated IFNγ response. Accordingly, these patients had the best prognosis. A third subtype was dominated by M2-polarized macrophages with potent immune-suppressive factors such as TGFβ signaling and reactive stroma, and these patients had relatively inferior prognosis. Other subtypes showed more diverse immunologic features with intermediate prognoses. Finally, our analysis revealed a complex immune landscape consisting of both discrete clusters and continuous spectrum.
CONCLUSIONS: This study provides a conceptual framework to understand the tumor immune microenvironment of SCCs. Future work is needed to evaluate its relevance in the design of combination treatment strategies and guiding optimal selection of patients for immunotherapy. ©2019 American Association for Cancer Research.

Entities:  

Year:  2019        PMID: 30833271      PMCID: PMC6571041          DOI: 10.1158/1078-0432.CCR-18-4085

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  46 in total

1.  Are clusters found in one dataset present in another dataset?

Authors:  Amy V Kapp; Robert Tibshirani
Journal:  Biostatistics       Date:  2006-04-12       Impact factor: 5.899

Review 2.  The blockade of immune checkpoints in cancer immunotherapy.

Authors:  Drew M Pardoll
Journal:  Nat Rev Cancer       Date:  2012-03-22       Impact factor: 60.716

3.  Safety, activity, and immune correlates of anti-PD-1 antibody in cancer.

Authors:  Suzanne L Topalian; F Stephen Hodi; Julie R Brahmer; Scott N Gettinger; David C Smith; David F McDermott; John D Powderly; Richard D Carvajal; Jeffrey A Sosman; Michael B Atkins; Philip D Leming; David R Spigel; Scott J Antonia; Leora Horn; Charles G Drake; Drew M Pardoll; Lieping Chen; William H Sharfman; Robert A Anders; Janis M Taube; Tracee L McMiller; Haiying Xu; Alan J Korman; Maria Jure-Kunkel; Shruti Agrawal; Daniel McDonald; Georgia D Kollia; Ashok Gupta; Jon M Wigginton; Mario Sznol
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

4.  Safety and activity of anti-PD-L1 antibody in patients with advanced cancer.

Authors:  Julie R Brahmer; Scott S Tykodi; Laura Q M Chow; Wen-Jen Hwu; Suzanne L Topalian; Patrick Hwu; Charles G Drake; Luis H Camacho; John Kauh; Kunle Odunsi; Henry C Pitot; Omid Hamid; Shailender Bhatia; Renato Martins; Keith Eaton; Shuming Chen; Theresa M Salay; Suresh Alaparthy; Joseph F Grosso; Alan J Korman; Susan M Parker; Shruti Agrawal; Stacie M Goldberg; Drew M Pardoll; Ashok Gupta; Jon M Wigginton
Journal:  N Engl J Med       Date:  2012-06-02       Impact factor: 91.245

5.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking.

Authors:  Matthew D Wilkerson; D Neil Hayes
Journal:  Bioinformatics       Date:  2010-04-28       Impact factor: 6.937

6.  Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.

Authors:  Alberto Calabrò; Tim Beissbarth; Ruprecht Kuner; Michael Stojanov; Axel Benner; Martin Asslaber; Ferdinand Ploner; Kurt Zatloukal; Hellmut Samonigg; Annemarie Poustka; Holger Sültmann
Journal:  Breast Cancer Res Treat       Date:  2008-07-01       Impact factor: 4.872

7.  Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules.

Authors:  Andrew E Teschendorff; Sergio Gomez; Alex Arenas; Dorraya El-Ashry; Marcus Schmidt; Mathias Gehrmann; Carlos Caldas
Journal:  BMC Cancer       Date:  2010-11-04       Impact factor: 4.430

8.  The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells.

Authors:  Cole Trapnell; Davide Cacchiarelli; Jonna Grimsby; Prapti Pokharel; Shuqiang Li; Michael Morse; Niall J Lennon; Kenneth J Livak; Tarjei S Mikkelsen; John L Rinn
Journal:  Nat Biotechnol       Date:  2014-03-23       Impact factor: 54.908

9.  Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds.

Authors:  Howard Y Chang; Julie B Sneddon; Ash A Alizadeh; Ruchira Sood; Rob B West; Kelli Montgomery; Jen-Tsan Chi; Matt van de Rijn; David Botstein; Patrick O Brown
Journal:  PLoS Biol       Date:  2004-01-13       Impact factor: 8.029

10.  Gene co-expression modules as clinically relevant hallmarks of breast cancer diversity.

Authors:  Denise M Wolf; Marc E Lenburg; Christina Yau; Aaron Boudreau; Laura J van 't Veer
Journal:  PLoS One       Date:  2014-02-07       Impact factor: 3.240

View more
  56 in total

1.  Identification of Regeneration and Hub Genes and Pathways at Different Time Points after Spinal Cord Injury.

Authors:  Sheng Fang; An-Quan Wang; Lin Zhong; Hui Zhang; Zong-Sheng Yin
Journal:  Mol Neurobiol       Date:  2021-01-23       Impact factor: 5.590

2.  swCAM: estimation of subtype-specific expressions in individual samples with unsupervised sample-wise deconvolution.

Authors:  Lulu Chen; Chiung-Ting Wu; Chia-Hsiang Lin; Rujia Dai; Chunyu Liu; Robert Clarke; Guoqiang Yu; Jennifer E Van Eyk; David M Herrington; Yue Wang
Journal:  Bioinformatics       Date:  2021-12-14       Impact factor: 6.937

3.  Immune expression profile identification in a group of proliferative verrucous leukoplakia patients: a pre-cancer niche for oral squamous cell carcinoma development.

Authors:  Carlos Llorens; Beatriz Soriano; Lucia Trilla-Fuertes; Leticia Bagan; Ricardo Ramos-Ruiz; Angelo Gamez-Pozo; Cristina Peña; Jose V Bagan
Journal:  Clin Oral Investig       Date:  2020-09-11       Impact factor: 3.573

Review 4.  Cervical Cancer Immunotherapy: Facts and Hopes.

Authors:  Louise Ferrall; Ken Y Lin; Richard B S Roden; Chien-Fu Hung; T-C Wu
Journal:  Clin Cancer Res       Date:  2021-04-22       Impact factor: 12.531

5.  Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma.

Authors:  Amit Mittal; Mike Wang; Aurobind Vidyarthi; Diana Yanez; Gabriela Pizzurro; Durga Thakral; Erin Tracy; Oscar R Colegio
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.996

6.  Identification of immune subtypes of cervical squamous cell carcinoma predicting prognosis and immunotherapy responses.

Authors:  Yimin Li; Shun Lu; Shubin Wang; Xinhao Peng; Jinyi Lang
Journal:  J Transl Med       Date:  2021-05-24       Impact factor: 5.531

7.  Immunity-Related Gene Signature Identifies Subtypes Benefitting From Adjuvant Chemotherapy or Potentially Responding to PD1/PD-L1 Blockage in Pancreatic Cancer.

Authors:  Hao Qian; Hongzhe Li; Junjie Xie; Xiongxiong Lu; Fanlu Li; Weishen Wang; Xiaomei Tang; Minmin Shi; Linxi Jiang; Hongwei Li; Hao Chen; Chenghong Peng; Zhiwei Xu; Xiaxing Deng; Baiyong Shen
Journal:  Front Cell Dev Biol       Date:  2021-06-23

8.  YKT6, as a potential predictor of prognosis and immunotherapy response for oral squamous cell carcinoma, is related to cell invasion, metastasis, and CD8+ T cell infiltration.

Authors:  Zongcheng Yang; Guangxing Yan; Lixin Zheng; Wenchao Gu; Fen Liu; Wei Chen; Xiujie Cui; Yue Wang; Yaling Yang; Xiyan Chen; Yue Fu; Xin Xu
Journal:  Oncoimmunology       Date:  2021-06-23       Impact factor: 8.110

9.  Immune landscape and subtypes in primary resectable oral squamous cell carcinoma: prognostic significance and predictive of therapeutic response.

Authors:  Pengfei Diao; Yue Jiang; Yuanyuan Li; Xiang Wu; Jin Li; Chen Zhou; Lei Jiang; Wei Zhang; Enshi Yan; Ping Zhang; Xu Ding; Heming Wu; Hua Yuan; Jinhai Ye; Xiaomeng Song; Linzhong Wan; Yunong Wu; Hongbing Jiang; Yanling Wang; Jie Cheng
Journal:  J Immunother Cancer       Date:  2021-06       Impact factor: 13.751

10.  A Signature-Based Classification of Gastric Cancer That Stratifies Tumor Immunity and Predicts Responses to PD-1 Inhibitors.

Authors:  Song Li; Jing Gao; Qian Xu; Xue Zhang; Miao Huang; Xin Dai; Kai Huang; Lian Liu
Journal:  Front Immunol       Date:  2021-06-11       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.